The purpose of this study is to assess the single dose bioequivalence of Ondansetron ODFS 8mg
with Zofran ODT® (Containing Ondansetron 8 mg) in healthy, male and female adult, human study
participants under fed conditions.
The purpose is to monitor clinical status, adverse events, laboratory investigations and to
assess relative safety and tolerance of ondansetron formulations under fed conditions.